Anxiety Clinical Trials
129 studies are recruiting for anxiety in the United States right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
By city
Studies, page 6
-
Pharmacogenetically-guided Escitalopram Treatment for Pediatric Anxiety: Aiming to Improve Safety and Efficacy (PrEcISE)
This double-blind, 12-week study will consist include132 anxious youth who are randomized (1:1) to standard or pharmacogenetically-guided escitalopram dosing. Block randomization (1:1) will be stratified by sex and metabolizer status.
- Stage
- Phase 4
- Ages
- 12 to 17
- Site
- University of Cincinnati, Department of Psychiatry & Behavioral Neuroscience, Cincinnati, Ohio
- Run by
- University of Cincinnati
-
IN Midazolam vs IN Dexmedetomidine vs IN Ketamine During Minimal Procedures in Pediatric ED
Pain in young children has been universally under-recognized due to their inability to describe or localize pain. Improvements in pharmacological interventions are necessary to optimize patient and family experience and allow for successful and efficient procedure completion. This is the first stud…
- Stage
- Phase 4
- Ages
- 1 to 5
- Site
- University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma
- Run by
- University of Oklahoma
-
Evaluation of the H.O.O.V.E.S. Healing Intensives Program
The aim of this study is to measure the impact of these H.O.O.V.E.S. healing intensives on Veteran participants using several psychological instruments. The investigators are planning to administer the demographic questionnaires and psychological instruments to Veteran participants before the heali…
- Stage
- Not phased
- Ages
- 18 to 120
- Site
- George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City, Utah
- Run by
- VA Salt Lake City Health Care System
-
Creatine for Depressed Male and Female Methamphetamine Users
* Assess the antidepressant/anxiolytic effect of creatine in male and female methamphetamine users * Assess creatine's effect on methamphetamine use * Assess the safety of creatine in male methamphetamine users with depression
- Stage
- Phase 3
- Ages
- 18 to 59
- Site
- Montana State University College of Nursing (Missoula campus), Missoula, Montana
- Run by
- Montana State University
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.